Bone Marrow Transplantation

Bone marrow transplants have become a vital component in the treatment of certain blood cancers, aiming to control or cure the disease, extend life expectancy, and enhance quality of life. Stem cell transplants hold the potential to induce cancer remission or even cure it.

Our network provides cutting-edge protocols for bone marrow transplantation, facilitated through globally respected medical facilities and esteemed leaders in the field of medicine. These facilities are internationally renowned centers of excellence, boasting impressive success rates and the highest standards of care. Our multidisciplinary team of specialists includes world-renowned experts in hematology, medical oncology, and radiation oncology. Treatment plans are meticulously tailored to meet the unique needs of each patient.

Stem cells, found in the bone marrow and blood, play a crucial role in producing essential blood cells necessary for survival. However, hematological cancers and treatments like chemotherapy and radiation therapy can damage the bone marrow, impairing the stem cells’ ability to produce blood cells. In such cases, a transplant can serve to replenish the compromised bone marrow. Moreover, a stem cell transplant may also aid in combating the cancer itself, as donated cells possess the ability to target and eliminate cancer cells more effectively than the recipient’s immune cells.

Bone Marrow Transplantation in the first-of-its kind Center in Abu Dhabi

For our patients in the UAE, bone marrow transplantation is offered at the first-of-its kind center of excellence Abu Dhabi Stem Cell Center and its clinical base Yas Clinic Khalifa City Hospital.

The Abu Dhabi Stem Cells Center (ADSCC) has earned the distinction of being named the first Center of Excellence in Hematopoietic Stem Cell Transplantation. This prestigious recognition underscores ADSCC’s cutting-edge infrastructure and its commitment to delivering top-tier services in bone marrow transplantation.

ADSCC operates in alignment with the latest international, evidence-based practices, boasting a team of globally renowned experts at its helm. This dedication has enabled ADSCC to achieve optimal patient outcomes not only within the United Arab Emirates but also on a global scale.

As a Center of Excellence in Hematopoietic Stem Cell Transplantation, ADSCC offers a comprehensive range of both surgical and non-surgical clinical services, adhering to world-class healthcare standards. These services cater to patients requiring hematopoietic stem cell transplantation for the treatment of various blood diseases, including autologous stem-cell transplantation, allogeneic stem-cell transplantation, and CAR-T cell therapy.

Leveraging its vast experience and expertise, ADSCC remains committed to advancing medical research, fostering ongoing medical education, and providing valuable training opportunities for healthcare professionals across different healthcare facilities.

More than 4,200 bone marrow transplants (over 1,380 in pediatrics) had been performed by December 2019 in Hadassah Hospital.

In August 2018, the BMT department of Hadassah Hospital became the first Israeli bone marrow transplantation center that received full accreditation from the International Joint Accreditation Committee ISCT-EUROPE & EBMT (JACIE).

ORPHAN (RARE GENETIC) DISEASES, LYMPHOMA, LEUKEMIA

The Hospital has a vast experience of BMT not only in leukemia and lymphoma, but also in the treatment of non-malignant rare genetic (orphan) diseases in pediatrics. The treatment protocols in the Hospital demonstrate very good results, many children recover completely.

TYPES OF NON-MALIGANT DISEASES:

Various types of immunodeficiency
Osteopetrosis: Hadassah Hospital has one of the best achievements in the world — 100 % survival (!) for patients with a donor (not necessarily a relative)
All disorders of the bone marrow, including red blood cells, white blood cells, and platelets, e.g. Fanconi anemia (as per the statistics, the quantity of BMTs performed in Hadassah Hospital for patients with this disease is one of the largest in the world)

In Israel, Hadassah University Hospital is the leader in this sphere, mainly due to the qualification of its specialists.

The overall survival in non-malignant diseases is over 95 %.

SPECIALISTS OF THE CLINIC FOR THE RARE PEDIATRIC DISEASES TREATMENT

Professor Polina Stepensky — Chairman, Department of Bone Marrow Transplantation & Cancer Immunotherapy of Adults and Children, oncology hematologist.

Specialization: Leading BMT specialist. Not only Israeli experts in the sphere are consulting with her and applying her professional advice in the practise, but also top foreign experts ask Prof. Stepensky’s opinion; her knowledge and experience has helped to save dozens of children who were rejected by other hospitals. Experience: over 20 years.

Dr. Irina Zaidman — Head of the Pediatric unit of the Bone Marrow Transplantation department.

Specialization: BMT. A worldwide expert who has performed more than 400 successful BMT procedures. Experience: over 18 years.

TYPES OF MALIGANT DISEASES:

The Department of Bone Marrow Transplants stands at the forefront of international leadership in the treatment of leukemia, lymphatic, and solid malignant tumors.

Bone marrow transplantation is offered for the following types of cancer: